Core Viewpoint - The company has not disclosed specific revenue data for the Japanese market, indicating that it is a minor part of its overseas operations and does not significantly impact overall business performance [1] Group 1 - The company stated that the Japanese market is only one component of its overseas strategy [1] - The business contribution from the Japanese market is limited [1] - Overall operations will not be decisively influenced by the performance in Japan [1]

Core Viewpoint - The company anticipates stable growth in overseas markets, with Europe showing notable performance while the Americas face challenges due to economic policies [1] Group 1: Market Performance - By Q3 2025, all overseas regions are expected to demonstrate stable growth, with Europe being particularly strong [1] - The Americas market is experiencing pressure on growth rates due to the impact of economic policies [1] Group 2: Strategic Adjustments - In response to short-term market fluctuations and economic policy impacts, the company plans to actively adjust its market and competitive strategies [1] - The company aims to enhance customer budgets through a multi-product sales approach and is committed to investing resources to acquire new customer orders [1] Group 3: Long-term Vision - The company emphasizes a long-term approach, focusing on localized strategies in core global markets and refining operations to meet the new demands of value customers in niche markets [1] - Continuous innovation in research and development is a priority to improve competitiveness and profitability [1]

Core Insights - The company reported that its overall performance continues to improve, with a stable growth trend in business as of the first three quarters of 2025 [1] - Historically, the company's revenue has remained high in the second and fourth quarters [1] - The management team is committed to maintaining market insight and strategic focus to consolidate the operational results for 2025 [1]

Core Points - Aidi Te (301580.SZ) announced that major shareholders Junlian Xinkang and HAL have reduced their holdings in the company [1] - The reduction occurred between November 7, 2025, and November 12, 2025, with a total of 1,051,430 shares sold, bringing their combined holding to 9.9996% [1] - From August 21, 2025, to November 12, 2025, Junlian Xinkang and HAL sold a total of 2,907,390 shares, representing 2.7283% of the company's total equity [1] - The reduction plan has been completed ahead of schedule, and no further reductions are planned [1]

Core Points - The article reports that two major shareholders, Junlian Xinkang and HAL, have reduced their holdings in Aidi Te (301580.SZ) by a total of 2.7283% [1] - The reduction occurred between November 7, 2025, and November 12, 2025, where a total of 1,051,430 shares were sold, bringing their combined holding to 9.9996% [1] - The total shares sold by Junlian Xinkang and HAL from August 21, 2025, to November 12, 2025, amounted to 2,907,390 shares, which represents 2.7283% of the company's total equity [1] Summary by Sections - **Shareholder Actions** - Junlian Xinkang and HAL have completed their share reduction plan ahead of schedule [1] - The reduction was executed through block trades and centralized bidding [1] - **Holding Changes** - Post-reduction, the combined shareholding of Junlian Xinkang and HAL is now 9.9996% [1] - The reduction touched both the 1% threshold and the 5% integer multiple [1]

Core Viewpoint - The company believes its market valuation is reasonable and highlights several driving factors for growth in the dental medical device industry, despite concerns about potential demand decline for dental restoration materials in the future [1] Industry Analysis - **Demographic Trends**: The aging population is leading to a rigid increase in demand for dental repair and treatment medical devices as oral health deteriorates with age [1] - **Health Awareness**: Rising living standards and increased health consciousness among younger demographics are driving demand for dental aesthetics [1] - **Technological Advancements**: The application of advanced technologies such as 3D printing, CAD/CAM systems, and digital dental implants is significantly enhancing the quality of dental repair services and patient comfort, promoting product innovation [1] - **Policy Support**: The government is prioritizing oral health, implementing policies and plans that foster orderly development in the dental medical industry, creating a favorable environment for growth [1] - **Domestic Substitution**: The acceleration of domestic substitution is expected as the company strengthens its technological innovation and brand development, leading to a decline in market share for imported products [1]

Core Viewpoint - The company, Aidi Te (301580.SZ), has indicated that it is open to future acquisitions related to zirconia production, contingent upon regulatory disclosures [2] Group 1 - The company has a stake in Jingdezhen Wanwei New Materials Co., Ltd., which primarily engages in the production and sales of zirconia powder [2] - The company will adhere to relevant regulations for any future acquisition plans [2]

Group 1 - Aidi Te's board meeting was held on November 11, 2025, to discuss the election of non-independent director candidates for the fourth board [1] - Aidi Te's revenue for the year 2024 is entirely derived from the medical device industry, accounting for 100% [1] - The current market capitalization of Aidi Te is 4.8 billion yuan [2] Group 2 - Prior to the arrest of the chairman of Peking University Medicine, police investigated the group's factory, indicating potential issues within the company [2] - There are concerns regarding the disposal of group assets and the unclear whereabouts of significant funds [2]

爱迪特（秦皇岛）科技股份有限公司 独立董事提名人声明与承诺 提名人爱迪特（秦皇岛）科技股份有限公司董事会现就提名贾国军为爱 迪特（秦皇岛）科技股份有限公司第四届董事会独立董事候选人发表公开声明。 被提名人已书面同意作为爱迪特（秦皇岛）科技股份有限公司第四届董事会独 立董事候选人（参见该独立董事候选人声明）。本次提名是在充分了解被提名 人职业、学历、职称、详细的工作经历、全部兼职、有无重大失信等不良记录 等情况后作出的，本提名人认为被提名人符合相关法律、行政法规、部门规章、 规范性文件和深圳证券交易所业务规则对独立董事候选人任职资格及独立性 的要求，具体声明并承诺如下事项： 一、被提名人已经通过爱迪特（秦皇岛）科技股份有限公司第三届董事 会提名委员会或者独立董事专门会议资格审查，提名人与被提名人不存在利害 关系或者其他可能影响独立履职情形的密切关系。 ☑ 是 □ 否 如否，请详细说明： 二、被提名人不存在《中华人民共和国公司法》第一百七十八条等规定 不得担任公司董事的情形。 ☑ 是 □ 否 如否，请详细说明： 三、被提名人符合中国证监会《上市公司独立董事管理办法》和深圳证 券交易所业务规则规定的独立董事任职资格 ...

爱迪特（秦皇岛）科技股份有限公司 独立董事候选人声明与承诺 声明人冯海兰作为爱迪特（秦皇岛）科技股份有限公司第四届董事会独 立董事候选人，已充分了解并同意由提名人爱迪特（秦皇岛）科技股份有限公 司董事会提名为爱迪特（秦皇岛）科技股份有限公司（以下简称该公司）第四 届董事会独立董事候选人。现公开声明和保证，本人与该公司之间不存在任何 影响本人独立性的关系，且符合相关法律、行政法规、部门规章、规范性文件 和深圳证券交易所业务规则对独立董事候选人任职资格及独立性的要求，具体 声明并承诺如下事项： 一、本人已经通过爱迪特（秦皇岛）科技股份有限公司第三届董事会提 名委员会或者独立董事专门会议资格审查，提名人与本人不存在利害关系或者 其他可能影响独立履职情形的密切关系。 ☑ 是 □ 否 如否，请详细说明： 二、本人不存在《中华人民共和国公司法》第一百七十八条等规定不得 担任公司董事的情形。 ☑ 是 □ 否 如否，请详细说明： 三、本人符合中国证监会《上市公司独立董事管理办法》和深圳证券交 易所业务规则规定的独立董事任职资格和条件。 ☑ 是 □ 否 如否，请详细说明： 四、本人符合该公司章程规定的独立董事任职条件。 ☑ 是 ...